Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Inula viscosa extract is a botanical preparation derived from the leaves of the *Inula viscosa* (syn. *Dittrichia viscosa*) plant, a perennial herb traditionally used in Mediterranean medicine. The extract contains diverse bioactive constituents, primarily sesquiterpene lactones (such as alantolactone and isoalantolactone) and polyphenols like chlorogenic acid. It demonstrates a broad pharmacological profile including anti-inflammatory, antimicrobial, antifungal, and antineoplastic activities. In oncology, the extract promotes apoptosis and inhibits cell cycle progression by downregulating key oncogenic drivers such as c-MYC, Cyclin D1, and anti-apoptotic proteins like Bcl-2. Clinically, it has been investigated for its hemostatic and regenerative properties, specifically in reducing postoperative bleeding and enhancing socket healing following dental surgery.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on inula viscosa extract.